HELMINTOX 125 mg/2.5 ml, oral suspension bottle, 15 ml
Active ingredients: Pyrantel pamoate, Pyrantel
Commercialized according to BDPM
Oral suspensionbottle, 15 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- HELMINTOX 125 mg/2,5 ml, suspension buvable
- Pharmaceutical form
- suspension buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) en verre de 15 ml avec cuillère-mesure polystyrène
- Marketing authorisation holder
- INNOTECH INTERNATIONAL
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Mar 1989
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67669621CIP73305622CIP133400933056223Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| EMBONATE DE PYRANTELsuspension | 14,420 g · 100 ml de suspension buvable | SA |
| PYRANTEL BASEsuspension | 5 g · 100 ml de suspension buvable | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.